MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The Polymorphism of SREBF1 Gene rs11868035 G/A Is Associated with susceptibility to Parkinson’s disease in a Chinese Population

F. Lou, M. Li, XG. Luo, Y. Ren (Shenyang, China)

Meeting: 2018 International Congress

Abstract Number: 1314

Keywords: Lysosomal disorders, Parkinsonism

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Genetics

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: The potential association between the single-nucleotide polymorphism of two functional genes (SREBF1gene rs11868035 and USP25 gene rs2823357) and susceptibility to Parkinson’s disease (PD) in people of Northeast China was examined in the present study.

Background: Recently, genome-wide association studies have successfully identified single-nucleotide polymorphism rs11868035 near sterol regulatory element binding transcription factor1 (SREBF1) and SNP rs2823357 near Ubiquitin specific peptidase 25 (USP25) as susceptibility loci for PD. SNP rs11868035 lies in an intron of SREBF1 gene on Chr17, which is a modifier of low density lipoprotein receptor and some genes involved in sterol biosynthesis. Recent study demonstrated that SREBF1 links lipogenesis to mitophagy, and also found carriers of the USP25 rs2823357 varriant had progressed to α-synucleinopathies of PD faster than others. However, this has not been confirmed in Chinese population. In the present study we examined the association of the polymorphism of both two genes with susceptibility of PD using a case control study.

Methods: 649 cases of Parkinson’s disease from consecutive outpatient and inpatient ward of our hospital were included in this retrospective study, and 355 healthy people were also included as control group. The technique of Kompetitive Allele Specific PCR was applied to determine the frequency distribution of genotype and allele gene of rs11868035 and rs2823357 in both groups.

Results: The significant association was observed for SREBF1 gene rs11868035 in G carriers in PD patients. The frequency of GA+GG genotype and G allele in PD group is significantly higher than in control group of SREBF1 gene rs11868035 (P<0.0001). As for USP25, there was no significant difference in the distributions of genotypes and alleles of rs2823357 between PD patients and controls (P>0.05). PD patients with G/A variant have higher UPDRSⅡ+Ⅲ score and lower MMSE score than non-carriers. The results were statistically different (P=0.017, P=0.003, respective).

Conclusions: Polymorphism of SREBF1 gene rs11868035 may increase susceptibility to Parkinson’s disease in northeastern Chinese population. USP25 gene rs2823357 variants may have no association with susceptibility to Parkinson’s disease in northeastern Chinese. PD patients with G/A variant have worsened motor and cognitive function.

To cite this abstract in AMA style:

F. Lou, M. Li, XG. Luo, Y. Ren. The Polymorphism of SREBF1 Gene rs11868035 G/A Is Associated with susceptibility to Parkinson’s disease in a Chinese Population [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/the-polymorphism-of-srebf1-gene-rs11868035-g-a-is-associated-with-susceptibility-to-parkinsons-disease-in-a-chinese-population/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-polymorphism-of-srebf1-gene-rs11868035-g-a-is-associated-with-susceptibility-to-parkinsons-disease-in-a-chinese-population/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley